IM Cannabis Corp. Amends Warrant Terms

Ticker: IMCC · Form: 6-K · Filed: 2025-08-13T00:00:00.000Z

Sentiment: neutral

Topics: warrants, amendment, private-placement

TL;DR

IM Cannabis Corp. changed the terms on warrants from a Nov 2024 private placement.

AI Summary

On August 13, 2025, IM Cannabis Corp. amended terms for common share purchase warrants originally issued in a private placement on November 12, 2024. These warrants were exercisable immediately at C$4 per share.

Why It Matters

This filing indicates a potential restructuring or modification of outstanding warrants, which could impact future share dilution and the company's capital structure.

Risk Assessment

Risk Level: medium — Amendments to warrant terms can signal changes in the company's financial strategy or market perception, potentially affecting share value.

Key Numbers

Key Players & Entities

FAQ

What specific amendments were made to the common share purchase warrants?

The filing states that agreements were entered into with holders of certain common share purchase warrants to amend their terms, but does not specify the exact nature of the amendments.

When were the original warrants issued?

The warrants were originally issued as part of a private placement offering that closed on November 12, 2024.

What was the original exercise price of the warrants?

The warrants were exercisable immediately upon issuance at an exercise price of C$4.

What is the filing number for this report?

The SEC file number is 001-40065.

What type of report is this filing?

This is a Form 6-K report, which is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.

From the Filing

0001178913-25-002871.txt : 20250813 0001178913-25-002871.hdr.sgml : 20250813 20250813170353 ACCESSION NUMBER: 0001178913-25-002871 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20250813 FILED AS OF DATE: 20250813 DATE AS OF CHANGE: 20250813 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IM Cannabis Corp. CENTRAL INDEX KEY: 0001792030 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40065 FILM NUMBER: 251212711 BUSINESS ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 BUSINESS PHONE: 416-256-4202 MAIL ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 6-K 1 zk2533630.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934   For the month of August 2025 (Report No. 3) .   Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executive offices)   Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ☒       Form 40-F ☐ CONTENTS Amendment to Common Share Purchase Warrants   On August 13, 2025, IM Cannabis Corp. (the “ Company ”) entered into agreements with the holders of certain common share purchase warrants (the “ Warrants ”) originally issued by the Company as part of its private placement offering that closed on November 12, 2024 (the “ 2024 Private Placement ”). The Warrants were exercisable immediately upon issuance at an exercise price of C$4.32 per common share and had a termination date of November 12, 2026. Pursuant to the August 13, 2025 amendments (the “ Amendments ”), the Company reduced the exercise price of each Warrant from C$4.32 per common share to C$3.43 per common share and extended the expiration date of each Warrant from November 12, 2026 to July 31, 2030. Except as set forth above, all other terms of the Warrants remain unchanged and in full force and effect. The foregoing descriptions of the Warrants and the Amendments contained herein do not purport to be complete and are qualified in their entirety by reference to the Form of Warrant and the Form of Amendment, which are attached as Exhibits 99.1 and 99.2, respectively, to this Report of Foreign Private Issuer on Form 6-K and are incorporated herein by reference.     Press Release   On August 13, 2025, the Company issued a press release titled: “IM Cannabis Announces Warrant Amendments and Form F-3 Resale Registration Statement Filing ”. A copy of this press release is furnished herewith as Exhibit 99.3.   Incorporation by Reference   This Report of Foreign Private Issuer on Form 6-K is incorporated by reference into the Company’s Registration Statements on Form F-3 (File No. 333-288346 and 333-289571 ) filed with the Securities and Exchange Commission to be a part thereof from the date on which this Report of Foreign Private Issuer on Form 6-K is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.   EXHIBIT INDEX   Exhibit No.   99.1 Form of Common Warrant (incorporated herein by reference to Exhibit 4.4 to the Company’s Registration Statement on Form F-3 (File No. 333-289571) filed with the SEC on August 13, 2025) 99.2 Form of Amendment to Common Warrant (incorporated herein by reference to Exhibit 4.5 to Company’s Registration Statement on Form F-3 (File No. 333-289571) filed with the SEC on August 13, 2

View on Read The Filing